Notably, BRAF mutations are seen at particularly high rates in melanoma, colorectal cancer (CRC), lung cancer, and papillary thyroid carcinomas (PTCs) [15,26,27,28,29,30,31] (Figure 4a). This evidence concerns the gene BRAF and melanoma.